CAS 10447-21-9
:2H-Quinolizin-1(6H)-one, hexahydro-
Description:
2H-Quinolizin-1(6H)-one, hexahydro- is a bicyclic compound that belongs to the class of quinolizines, which are characterized by a fused ring system containing both a benzene and a pyridine-like structure. This compound features a saturated hexahydro structure, indicating that it has undergone hydrogenation, resulting in a fully saturated ring system. Its molecular structure contributes to its potential biological activity, making it of interest in medicinal chemistry. The presence of the quinolizinone moiety suggests that it may exhibit various pharmacological properties, including antimicrobial or antitumor activities. The compound's CAS number, 10447-21-9, allows for precise identification in chemical databases. Typically, such compounds are studied for their reactivity, stability, and potential applications in drug development. Additionally, the physical properties, such as solubility and melting point, can vary based on the specific substituents and the overall molecular configuration, influencing its behavior in biological systems and chemical reactions.
Formula:C9H15NO
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
Octahydro-1H-quinolizin-1-one
CAS:<p>Octahydro-1H-quinolizin-1-one is a drug that has been shown to be an effective treatment for inflammatory diseases, including inflammatory bowel disease and mucopolysaccharidosis. It binds to the M1 receptors in tissues, which leads to the inhibition of proinflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF). Octahydro-1H-quinolizin-1-one also has been shown to be an allosteric modulator for the IL-4 receptor. The drug also inhibits etoposide induced apoptosis in cancer cells, suggesting it may have therapeutic potential against cancer.</p>Formula:C9H15NOPurity:Min. 95%Molecular weight:153.22 g/mol
